BRCAness refers to tumors that mimic BRCA1/2 mutation behavior, making them vulnerable to DNA-damaging treatments like PARP ...

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416). Number of patients and ...

Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But ...

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, ...

Former EastEnders star has revealed that she has undergone a double mastectomy, following a gene test which confirmed she ...

Genetic testing for hereditary cancer unexpectedly uncovers a case of myelodysplastic syndrome (MDS), highlighting the need ...

This can be performed on the tumor tissue itself to identify changes called somatic mutations that ... more commonly ...

Supplemental Health Care (SHC) released its 2025 Impact Report, highlighting the organization's ongoing dedication to enhancing its impact on behavioral health, education, and healthcare across the ...

Seismic Therapeutic, Inc., the machine learning immunology company, today announced the appointment of Sophie Jones, M.D., as the company's Chief Financial Officer, effective June 18, 2025. In this ...

There were 22 men with progressive mCRPC enrolled, the median age at enrollment was 66 years (range 52-80), the median PSA at original diagnosis was 82 ng/mL (range 5-3,648), 55% had a Gleason score 9 ...

Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains ...